Market Cap (In INR)
2.47 Billion
Revenue (In INR)
1.08 Billion
Net Income (In INR)
167.76 Million
Avg. Volume
31.11 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 71.0-144.6
- PE
- -
- EPS
- -
- Beta Value
- 1.038
- ISIN
- INE385I01010
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Mahendra Singh Chawla
- Employee Count
- -
- Website
- https://www.alpalabs.in
- Ipo Date
- 2007-08-07
- Details
- Alpa Laboratories Limited manufactures and sells pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.
More Stocks
-
3181
-
BMTLFBeMetals Corp.
BMTLF
-
YAL
-
ENBEnbridge Inc.
ENB
-
BNBR3
-
017180MYUNGMOON Pharm co.,Ltd
017180
-
NEWCAPNewcap Holding A/S
NEWCAP
-
URB-AUrbana Corporation
URB-A